Top Markets
#1 TENDIES TENDIES +37.02%
#2 Cash Cat Cash Cat +24.00%
#3 Asteroid Shiba Asteroid Shiba +16.86%
#4 OSK OSK +15.36%
#5 龙虾 (Lobster) 龙虾 (Lobster) +11.30%
#6 Bluwhale Bluwhale +10.73%
#7 MarsCoin MarsCoin +8.62%
#8 ROLL ROLL +7.54%
#9 CARV CARV +7.24%
#10 Pyth Network Pyth Network +7.13%
Coin of the day
TENDIES TENDIES
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Guiyang Xintian Pharmaceutical Co.,Ltd. Guiyang Xintian Pharmaceutical Co.,Ltd.

Guiyang Xintian Pharmaceutical Co.,Ltd.

002873
Rangering i aksjer #16491
Guiyang Xintian Pharmaceutical Co.,Ltd. is a Chinese company dedicated to the... Guiyang Xintian Pharmaceutical Co.,Ltd. is a Chinese company dedicated to the research, development, production, and commercialization of traditional Chinese medicines (TCMs) for a wide range of ailments. Its product offerings include various pharmaceutical formulations such as hard capsules, gels, mixtures, granules, and tablets. These medicines are specifically designed to treat diverse medical conditions, including antitumor applications, gynecological issues, urinary tract problems, breast and thyroid disorders, blood-related illnesses, heat-related syndromes, oral health complaints, common colds, and cardiovascular diseases. The company was founded in 1995 and is headquartered in Guiyang, China.
Aksjekurs
$1.23
Markedsverdi
$290.17M
Endring (1 dag)
-2.52%
Endring (1 år)
-28.01%
Land
CN
Handel Guiyang Xintian Pharmaceutical Co.,Ltd. (002873)

Kategori

Healthcare
Inntekter for Guiyang Xintian Pharmaceutical Co.,Ltd. (002873)
Inntekter i 2026 TTM: 0
Ifølge Guiyang Xintian Pharmaceutical Co.,Ltd. sine nyeste økonomiske rapporter er selskapets nåværende resultat 0. I 2026 hadde selskapet et resultat på 0, lik resultatet i 2026, som var 0. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for Guiyang Xintian Pharmaceutical Co.,Ltd. fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH